Sunshine Biopharma Inc (SBFM)

[TraderAI]

Adva-27a is 2032/3 in USA (patent exp).

They filed it in other countries but it has to get approval at least somewhere. To date, no progress.

If SBFM was not successful 10 years, especially saying it would be the best on the market, why do it again 10 years LATER with adva-27a?

Might be another 10-15 years because nothing ever started.

That 10-15 year timeline generally is for BigPharma and doesn’t really make sense for someone as small as SBFM who can’t even manufacture vitamin C because they have no pharmaceutical plant and have to buy vitamins or anything from a outside supplier.

Same with SBFM-PL-4. It was filed in 2020 but zero update on its status at the FDA and patent office, so where is it? Did it get denied?

K1.1 has a provisional patent date of 2022, but it’s like starting all over again, another 10-15 year wait. Same exact thing, we filed.

WHAT IS THE STATUS with the FDA and US Patent filing? What's the filing numbers? Nobody has ever seen anything except "we filed.". Yes, anyone can file! Most don't ever get approved. And what was that weird SEC exchange with Slilaty with a file number located here:

https://www.sec.gov/Archives/edgar/data/1402328/000000000022005515/filename1.pdf


Steve Slilaty
Chief Executive Officer
Sunshine Biopharma, Inc
6500 Trans-Canada Highway, 4th Floor
Pointe-Claire, Quebec, Canada H9R 0A5
Re: Sunshine Biopharma, Inc

Registration Statement on Form S-3

Filed May 10, 2022

File No. 333-264830

Dear Dr. Slilaty:

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Alyssa Wall at 202-551-8106 with any questions.

Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc: Jeff Cahlon

It all depends on approval which they never got for ANYTHING from the FDA.

What worries me is if SBFM does delist, I think all the SBFMW warrants become worthless because they cannot be exercised at $4.25 if there is no NASDAQ ticker called SBFM. I’ve never seen this happen before and don’t know the answer.

Then they have to get to do this if they ever get anything approved:

Clinical stage 1 (this would be huge)
Clinical Stage 2 (even better)
Clinical Stage 3 (this would be great but even so we are looking at 10% as compared to BigPharma with same timelines)

Get the FDA and patent approval and I may change my mind, but then there’s the 10-15 year wait……..And 90% chance of a failure or side effects and it’s back to the drawing board to correct it and start the process all over again)